Enhancing pediatric oncology clinical trials through patient reported outcomes (PROs)
Survival rates of children with cancer have significantly increased over the last decades in high income countries. However, cancer survivors often face significant long-term adverse effects on physical, psychosocial, and neurocognitive health. The use of Patient-Reported Outcomes (PROs) in clinical...
Saved in:
| Main Authors: | David Riedl, Niclas Hubel, Annalena Endres, Chiara Vetrano, Andreas Meryk, Roman Crazzolara |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | EJC Paediatric Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772610X2400059X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of positive mental well-being on patient reported outcome (PRO): finding from a cross-sectional multi-disease study in China
by: Zhihao Yang, et al.
Published: (2024-11-01) -
Trajectory, interactions, and predictors of higher symptom burden during induction therapy for multiple myeloma
by: Mona Kamal, et al.
Published: (2024-12-01) -
Risdiplam: therapeutic effects and tolerability in a small cohort of 6 adult type 2 and type 3 SMA patients
by: Gianmarco Severa, et al.
Published: (2024-11-01) -
SarkoLife: quality of life in patients undergoing multimodal soft tissue sarcoma treatment
by: Sebastian Hoffmann, et al.
Published: (2025-01-01) -
Mechanistic insights into PROS1 inhibition of bladder cancer progression and angiogenesis via the AKT/GSK3β/β-catenin pathway
by: Xin-peng Fan, et al.
Published: (2025-02-01)